KÇKerem Çil

Kerem Çil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kerem Çil has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gene-based map of cardiovascular diseases

    by Barış Kayaalp, Kerem Çil, Tayfun Özçelik

    Background: Rare coding variants contribute to cardiovascular disease, but their effects across disease groups remain incompletely characterized. In particular, the influence of functionally and clinically informed variant classification and sex-specific genetic effects on gene–phenotype associations remains understudied. Methods: We analyzed whole-genome sequencing data from up to 483,311 UK Biobank participants across six genetic ancestry groups and eight cardiovascular phenotype groups. Gene-burden testing integrated state-of-the-art missense classification and predicted pathogenic germline variants. We performed combined-sex and sex-stratified analyses, followed by cross-ancestry meta-analysis. We additionally adjusted for cardiometabolic traits in sensitivity analyses, estimated penetrance among qualifying-variant carriers, and assessed genetic prevalence across eight ancestry groups. Results: We identified 86 exome-wide significant gene–phenotype associations: 40 established and 46 novel. Novel associations included EHMT2 with atrial fibrillation, P2RX1 with arrhythmias, P2RY4 with complete atrioventricular block, and NOSTRIN with atherosclerotic heart disease in females. After cardiometabolic adjustment, 60 associations retained exome-wide significance and 18 additional associations emerged, including CDH11 , PARVA , and ADAMDEC1 with atherosclerosis-related phenotypes. Conclusions: These findings identify novel cardiovascular gene–phenotype associations implicating purinergic signaling, endothelial nitric oxide regulation, and vascular wall biology. Variant selection shapes penetrance estimates and the interpretation of inherited susceptibility.

  • Prediction of human missense variant effects from functional evidence

    by Barış Kayaalp, Kerem Çil, Clément Conil, Aurélie Cobat, Meltem Ece Kars, Yuval Itan, Jean-Laurent Casanova, Tayfun Özçelik


  • Open Access

    Gene-based map of cardiometabolic diseases

    by Barış Kayaalp, Kerem Çil, Onur Emre Onat, Tayfun Özçelik

    Cardiometabolic disorders are common, interrelated conditions with substantial genetic contribution. We performed sex- and ancestry-stratified rare-variant gene-burden analyses in UK Biobank across obesity, fatty liver disease, dyslipidemia, hypertension, chronic kidney disease, and diabetes mellitus, with Turkish Variome contributing to obesity analyses, using state-of-the-art variant classification tools. This approach replicated established gene–phenotype relationships and expanded the number of causal cardiometabolic gene–phenotype associations from 368 to 534. Complementary genetic-epidemiological analyses showed that approximately one in six individuals carries risk-increasing alleles and one in nine carries protective alleles.


  • Open Access

    Prediction of human missense variant effects from functional evidence

    by Tayfun Ozcelik, Barış Kayaalp, Kerem Çil, Clément Conil, Aurélie Cobat, Meltem Ece Kars, Yuval Itan, Jean-Laurent Casanova

    Prediction of missense variant effects remains the critical bottleneck in disease gene identification and clinical interpretation. Current predictors rely on clinical outcomes or population patterns, rather than direct measures of functional impact, leading to limited generalizability and data circularity. We present FuncVEP, the first family of variant effect predictors trained exclusively on balanced and diverse functional data, providing a direct representation of functional effect. FuncVEP generalizes across contexts, outperforming 47 existing predictors on both clinical and functional benchmarks, improving the accuracy from 82% to 93% and reducing uncertain classifications from 11% to 2%. To illustrate its utility in gene discovery, we applied FuncVEP to 490 inborn errors of immunity genes in the UK Biobank and Mount Sinai Million Health Discoveries Program, identifying 50 novel gene–phenotype associations. FuncVEP provides a robust, scalable solution for variant interpretation, advancing both diagnostic precision and gene discovery.